We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

65 hedge funds and large institutions have $266M invested in Tandem Diabetes Care in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

26% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 19

7% more funds holding

Funds holding: 61 → 65 (+4)

11% less capital invested

Capital invested by funds: $300M → $266M (-$34.1M)

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
24
Reduced
19
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCP
TAMRO Capital Partners
Virginia
+$14.8M
2
Millennium Management
Millennium Management
New York
+$4.16M
3
Franklin Resources
Franklin Resources
California
+$3.2M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$2.54M
5
Jennison Associates
Jennison Associates
New York
+$2.5M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$8.06M
2
JP Morgan Chase
JP Morgan Chase
New York
-$7.86M
3
WA
Wasatch Advisors
Utah
-$3M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$2.86M
5
CCM
Catapult Capital Management
New York
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
51
ProShare Advisors
Maryland
$206K +$238K +932 New
PNC Financial Services Group
52
PNC Financial Services Group
Pennsylvania
$175K +$202K +793 New
NFA
53
Nationwide Fund Advisors
Ohio
$157K +$2.29K +9 +1%
MCM
54
Manchester Capital Management
Vermont
$145K – – –
AIG
55
American International Group
New York
$138K +$3.83K +15 +2%
BA
56
BlackRock Advisors
Delaware
$107K +$9.95K +39 +9%
Deutsche Bank
57
Deutsche Bank
Germany
$60K +$23.7K +93 +50%
Citigroup
58
Citigroup
New York
$31K -$80.1K -314 -69%
MWP
59
MYCIO Wealth Partners
Pennsylvania
$22K – – –
Barclays
60
Barclays
United Kingdom
$8K -$2.04K -8 -18%
U
61
UBS
Switzerland
$7K +$8.16K +32 New
TDC
62
Thompson Davis & Co
Virginia
$6K – – –
Bank of America
63
Bank of America
North Carolina
$3K -$13K -51 -81%
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
$351 -$2.29K -9 -82%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$165 +$190K +745 New
Goldman Sachs
66
Goldman Sachs
New York
– -$8.06M -31,270 Closed
Schroder Investment Management Group
67
Schroder Investment Management Group
United Kingdom
– -$2.86M -11,090 Closed
CCM
68
Catapult Capital Management
New York
– -$1.73M -6,710 Closed
GACM
69
Green Arrow Capital Management
New York
– -$1.55M -6,000 Closed
BS
70
Bow Street
New York
– -$1.45M -5,625 Closed
LCG
71
Lisanti Capital Growth
New York
– -$501K -1,943 Closed
Tudor Investment Corp
72
Tudor Investment Corp
Connecticut
– -$497K -1,930 Closed
GGHC
73
Gilder Gagnon Howe & Co
New York
– -$296K -1,149 Closed
SO
74
STRS Ohio
Ohio
– -$94.3K -370 Closed
TRCT
75
Tower Research Capital (TRC)
New York
– -$13K -49 Closed
1 2
3

TNDM Hedge Fund Activity: Q1 2014 in Review

65 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2014, worth a combined $266M — down 11% from $300M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TNDM positions and 10 closed out — a net gain of 5 holders — while 24 added to existing stakes and 19 trimmed.

The largest buyer was TAMRO Capital Partners, opening a new position worth an estimated $14.8M. The largest seller was Goldman Sachs, exiting entirely with an estimated $8.06M sold.

  • 65 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2014, up from 61 in Q4 2013.
  • Funds reported $266M of Tandem Diabetes Care stock for Q1 2014, down 11% quarter-over-quarter.
  • 15 funds opened new Tandem Diabetes Care positions in Q1 2014 and 10 closed out, a net change of +5 holders.
  • The largest Tandem Diabetes Care buyer in Q1 2014 was TAMRO Capital Partners, an estimated $14.8M added.
  • The largest Tandem Diabetes Care seller in Q1 2014 was Goldman Sachs, an estimated $8.06M sold.

Based on aggregated 13F filings for Q1 2014.